Skip to content

Clinical trials

Phase 1/2 Squamous Cell Carcinoma of Head and Neck trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Cell Carcinoma of Head and Neck Phase: Phase 1/2 Country / region: Australia Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20152
20161
20171
20183
20201
20213
20224
20232
20243
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting10
Terminated7
Completed4
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
AstraZeneca1
Aulos Bioscience, Inc.1
Bristol-Myers Squibb1
Daiichi Sankyo1
Doma Biopharmaceutical(Suzhou)Co., Ltd.1
DualityBio Inc.1
Dynavax Technologies Corporation1
Fusion Pharmaceuticals Inc.1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Cell Carcinoma of Head and Neck23
Carcinoma, Non-Small-Cell Lung15
Melanoma14
Triple Negative Breast Neoplasms8
Uterine Cervical Neoplasms8
Carcinoma, Renal Cell7
Stomach Neoplasms7
Colorectal Neoplasms5
Neoplasm Metastasis5
Ovarian Neoplasms5

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.